Table 4.

Antecedents of Subsequent Diagnostic Shifts in Psychotic Disorders: Structural Equation Modeling

	Fit Indicesa			Path coefficientsb
	CFI	TLI	RMSEA	Baseline to month 6	6 months to year 2	Year 2 to year 10
Schizophrenia spectrum disorders
GAF	0.994	0.996	0.055	−0.25***	−0.06	−0.13*
Negative symptoms	0.991	0.994	0.064	0.29***	0.10	0.16**
Psychotic symptoms	0.996	0.996	0.054	0.09*	−0.01	0.11*
Depression symptoms	0.986	0.982	0.106	−0.08	−0.05	0.08
Antipsychotics	0.999	0.999	0.021	0.04	0.00	0.07
Bipolar disorder
GAF	0.994	0.996	0.049	0.32***	0.04	0.13*
Negative symptoms	0.993	0.996	0.055	−0.34***	0.00	−0.16*
Psychotic symptoms	0.986	0.983	0.108	0.01	0.00	−0.10
Depression symptoms	0.987	0.984	0.098	−0.14**	0.03	−0.12*
BPRS excitement	0.984	0.979	0.116	0.13**	0.07	−0.08
Anti-manic medication	0.996	0.997	0.051	0.18***	0.15*	−0.03
Major depression
GAF best	0.987	0.986	0.077	0.03	0.00	0.09
Negative symptoms	0.980	0.978	0.096	−0.04	0.02	−0.06
Psychotic symptoms	0.991	0.987	0.072	−0.28***	0.03	−0.12
Depression symptoms	0.984	0.982	0.086	0.36***	0.09	−0.08
Anti-depressants	0.994	0.993	0.056	0.27***	−0.12	0.01
Anti-manic medication	0.994	0.992	0.061	−0.15*	−0.15	0.08
Subtance-induced disorder
Substance treatment	0.996	0.995	0.026	0.25***	0.20	−0.03

NOTE. Variables were selected from significant associations found in the mixed-effects logistic regression analyses.

^aCFI = Comparative Fit Index; TLI = Tucker Lewis Index; RMSEA = Root Mean Square Error of Approximation.

^bStandardized path coefficient for the symptom or treatment characteristic at one wave to the diagnostic status at the next wave, controlling for diagnosis at the former wave.

^*p<0.05

^**p<0.01

^***p<0.001